Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

0.3520 +0.0042 (+1.21%)
Streaming Delayed Price Updated: 11:36 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Biodesix Announces Second Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Crash In Q3
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
Recap: Biodesix Q1 Earnings
Via Benzinga
Biodesix Earnings Perspective: Return On Capital Employed
Via Benzinga
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
From Biodesix, Inc.
Via Business Wire
Why Shares of CareDx Are Jumping Friday
The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services
From Biodesix, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday! 
Via InvestorPlace
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
From Biodesix, Inc.
Via Business Wire
Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces First Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
From Biodesix, Inc.
Via Business Wire
Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying
The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence... 
Via Benzinga
Looking Into Biodesix's Recent Short Interest
Biodesix's (NASDAQ:BDSX) short percent of float has risen 67.65% since its last report. The company recently reported that it has 347 thousand shares sold short, which is 0.57% of all regular shares... 
Via Benzinga
$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors
From Biodesix, Inc.
Via Business Wire
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine
From Biodesix, Inc.
Via Business Wire
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.